All treatments
Treatment
Fasenra 30 mg solution for injection in pre-filled syringe clinical trials
2 indexed studies · 0 currently recruiting
- Ongoing, recruitingTherapeutic confirmatory (Phase III)
A Multicentre, Randomised, Double-Blind, Parallel-Group, Placebo- Controlled Phase 3 Efficacy and Safety Study of Benralizumab in Patients with Eosinophilic Chronic Rhinosinusitis with Nasal Polyps (ORCHID)
This study looks at a new medicine called benralizumab for adults with severe nose polyps and asthma. It aims to see if it can shrink polyps and reduce stuffy noses better than a dummy treatment, using standard nasal sprays alongside.
For: Severe CRSwNP patients with asthma.Italy · Bulgaria · Hungary - Ongoing, recruitingTherapeutic confirmatory (Phase III)
A 52-week, randomised, double-blind, double-dummy, parallel group, multi-centre, non-inferiority study assessing exacerbation rate, additional measures of asthma control and safety in adult and adolescent severe asthmatic participants with an eosinophilic phenotype treated with GSK3511294 (depemokimab) compared with mepolizumab or benralizumab
This study looks at a new medicine called depemokimab for severe asthma with high eosinophils. It compares it to existing treatments like mepolizumab and benralizumab over a year to see if it's just as good at preventing asthma attacks and improving control.
For: Severe asthma with an eosinophilic phenotypeSlovenia · Netherlands · Portugal